Duke University Medical Center, Division Cell Therapy, Heme Malignancies Program

Durham, North Carolina 27710

0 studies enrolling now · 2 studies all time

What they study most

Hemoglobinuria, Paroxysmal, Paroxysmal Hemoglobinuria, Nocturnal

Studies at this site

• Extension Study of Eculizumab in Patients With Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) — Completed
• Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab — Completed